EA201170764A1 - Моноклональные антитела против ферропортина 1 и их применение - Google Patents
Моноклональные антитела против ферропортина 1 и их применениеInfo
- Publication number
- EA201170764A1 EA201170764A1 EA201170764A EA201170764A EA201170764A1 EA 201170764 A1 EA201170764 A1 EA 201170764A1 EA 201170764 A EA201170764 A EA 201170764A EA 201170764 A EA201170764 A EA 201170764A EA 201170764 A1 EA201170764 A1 EA 201170764A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- monoclonal antibodies
- application
- antibodies against
- iron
- maintaining
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Настоящее изобретение относится к моноклональным антителам и их антигенсвязывающим фрагментам, связывающим FPN1 человека и подавляющим его активность, обладающим эффективностью в условиях поддержания или усиления транспорта железа из клеток млекопитающего и/или поддержания или повышения концентрации железа в сыворотке, числа ретикулоцитов, числа красных кровяных телец, гемоглобина и/или гематокрита в организме индивида in vivo.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12007608P | 2008-12-05 | 2008-12-05 | |
US23981809P | 2009-09-04 | 2009-09-04 | |
PCT/US2009/066187 WO2010065496A1 (en) | 2008-12-05 | 2009-12-01 | Anti-ferroportin 1 monoclonal antibodies and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201170764A1 true EA201170764A1 (ru) | 2011-12-30 |
EA020472B1 EA020472B1 (ru) | 2014-11-28 |
Family
ID=41683589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201170764A EA020472B1 (ru) | 2008-12-05 | 2009-12-01 | Моноклональные антитела против ферропортина 1 и их применение |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP2373335B1 (ru) |
JP (1) | JP5713917B2 (ru) |
KR (1) | KR101353117B1 (ru) |
CN (1) | CN102238962B (ru) |
AR (1) | AR074398A1 (ru) |
AU (1) | AU2009322587B2 (ru) |
BR (1) | BRPI0922288A2 (ru) |
CA (1) | CA2745618C (ru) |
CY (1) | CY1117355T1 (ru) |
DK (1) | DK2373335T3 (ru) |
EA (1) | EA020472B1 (ru) |
ES (1) | ES2566343T3 (ru) |
HK (1) | HK1158977A1 (ru) |
HR (1) | HRP20160302T1 (ru) |
HU (1) | HUE028585T2 (ru) |
IL (1) | IL212731A0 (ru) |
MX (1) | MX2011005939A (ru) |
NZ (1) | NZ592545A (ru) |
PA (1) | PA8849601A1 (ru) |
PL (1) | PL2373335T3 (ru) |
SG (1) | SG171960A1 (ru) |
SI (1) | SI2373335T1 (ru) |
TW (1) | TW201023891A (ru) |
UA (1) | UA104741C2 (ru) |
WO (1) | WO2010065496A1 (ru) |
ZA (1) | ZA201103941B (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150013277A (ko) * | 2012-05-14 | 2015-02-04 | 제넨테크, 인크. | 종양의 진단 및 치료를 위한 조성물 및 방법 |
CN110806486B (zh) * | 2019-11-23 | 2023-03-21 | 中南大学湘雅三医院 | Mafg/as1/pcbp2/fpn1调控轴作为靶位点检测试剂的应用 |
CN113980987A (zh) * | 2021-12-06 | 2022-01-28 | 上海市农业科学院 | 一种提高植物抗镍性能的PgIREG1S和AlATP-PRTS双基因组及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7166448B1 (en) * | 1999-05-10 | 2007-01-23 | Children's Medical Center Corproation | Ferroportin1 nucleic acids and proteins |
IT1319221B1 (it) * | 2000-10-17 | 2003-09-26 | Antonello Pietrangelo | Mutazioni nel gene della ferroportina 1 associata ad emocromatosiereditaria. |
ES2500066T3 (es) * | 2008-01-25 | 2014-09-30 | Amgen, Inc | Anticuerpos frente a ferroportina y métodos de uso |
-
2009
- 2009-11-23 PA PA20098849601A patent/PA8849601A1/es unknown
- 2009-11-24 AR ARP090104529A patent/AR074398A1/es unknown
- 2009-11-25 TW TW098140185A patent/TW201023891A/zh unknown
- 2009-12-01 NZ NZ592545A patent/NZ592545A/xx not_active IP Right Cessation
- 2009-12-01 EA EA201170764A patent/EA020472B1/ru not_active IP Right Cessation
- 2009-12-01 BR BRPI0922288A patent/BRPI0922288A2/pt not_active IP Right Cessation
- 2009-12-01 PL PL09760073T patent/PL2373335T3/pl unknown
- 2009-12-01 UA UAA201107028A patent/UA104741C2/ru unknown
- 2009-12-01 KR KR1020117014053A patent/KR101353117B1/ko not_active IP Right Cessation
- 2009-12-01 HU HUE09760073A patent/HUE028585T2/en unknown
- 2009-12-01 AU AU2009322587A patent/AU2009322587B2/en not_active Ceased
- 2009-12-01 JP JP2011539625A patent/JP5713917B2/ja not_active Expired - Fee Related
- 2009-12-01 CA CA2745618A patent/CA2745618C/en not_active Expired - Fee Related
- 2009-12-01 CN CN200980148354.8A patent/CN102238962B/zh not_active Expired - Fee Related
- 2009-12-01 ES ES09760073.8T patent/ES2566343T3/es active Active
- 2009-12-01 EP EP09760073.8A patent/EP2373335B1/en active Active
- 2009-12-01 MX MX2011005939A patent/MX2011005939A/es active IP Right Grant
- 2009-12-01 DK DK09760073.8T patent/DK2373335T3/en active
- 2009-12-01 SI SI200931382T patent/SI2373335T1/sl unknown
- 2009-12-01 SG SG2011040797A patent/SG171960A1/en unknown
- 2009-12-01 WO PCT/US2009/066187 patent/WO2010065496A1/en active Application Filing
-
2011
- 2011-05-05 IL IL212731A patent/IL212731A0/en unknown
- 2011-05-27 ZA ZA2011/03941A patent/ZA201103941B/en unknown
- 2011-12-20 HK HK11113719.0A patent/HK1158977A1/zh not_active IP Right Cessation
-
2016
- 2016-03-23 HR HRP20160302TT patent/HRP20160302T1/hr unknown
- 2016-04-12 CY CY20161100296T patent/CY1117355T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
HUE028585T2 (en) | 2016-12-28 |
SI2373335T1 (sl) | 2016-04-29 |
KR20110084996A (ko) | 2011-07-26 |
JP5713917B2 (ja) | 2015-05-07 |
TW201023891A (en) | 2010-07-01 |
HRP20160302T1 (hr) | 2016-04-22 |
CY1117355T1 (el) | 2017-04-26 |
PL2373335T3 (pl) | 2016-08-31 |
KR101353117B1 (ko) | 2014-02-17 |
JP2012510814A (ja) | 2012-05-17 |
PA8849601A1 (es) | 2010-07-27 |
EA020472B1 (ru) | 2014-11-28 |
BRPI0922288A2 (pt) | 2018-08-28 |
EP2373335B1 (en) | 2016-02-24 |
CA2745618C (en) | 2014-06-10 |
WO2010065496A1 (en) | 2010-06-10 |
NZ592545A (en) | 2012-12-21 |
DK2373335T3 (en) | 2016-05-02 |
SG171960A1 (en) | 2011-07-28 |
EP2373335A1 (en) | 2011-10-12 |
CN102238962A (zh) | 2011-11-09 |
ZA201103941B (en) | 2012-11-28 |
AU2009322587A1 (en) | 2011-07-28 |
AR074398A1 (es) | 2011-01-12 |
CA2745618A1 (en) | 2010-06-10 |
CN102238962B (zh) | 2014-02-12 |
HK1158977A1 (zh) | 2012-07-27 |
UA104741C2 (ru) | 2014-03-11 |
IL212731A0 (en) | 2011-07-31 |
ES2566343T3 (es) | 2016-04-12 |
AU2009322587B2 (en) | 2013-09-26 |
MX2011005939A (es) | 2011-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201070553A1 (ru) | Антитела к гепцидину и варианты их применения | |
EA201170312A1 (ru) | Селективные антитела к гепцидину-25 и их применение | |
UA109633C2 (uk) | Антитіло людини проти тканинного фактора | |
UA116194C2 (uk) | Антитіло, яке специфічно зв'язується з людським альфа-синуклеїном | |
NZ596409A (en) | Anti macrophage migration inhibitory factor antibodies | |
EA201100641A1 (ru) | Антитела к il-6 и их применение | |
EA200701211A1 (ru) | Полипептиды, которые связываются с br3, и их применение | |
EA202091230A3 (ru) | Антагонисты активин-actrii и их применения для повышения уровней эритроцитов | |
EA200870020A1 (ru) | Человеческие моноклональные антитела против о8е | |
BRPI0613382A8 (pt) | anticorpos isolados, anticorpo monoclonal, célula de hibridoma, método de identificação, método de inibição do crescimento de uma célula, método de tratamento terapêutico, método de determinação da presença de uma proteína, métodos de diagnósticos da presença de tumor | |
BR112012008665A2 (pt) | tratamento de câncer | |
EA201070730A1 (ru) | Гуманизированные антитела, специфичные к фактору фон виллебранда | |
EA201892184A1 (ru) | Оптимизированные моноклональные антитела против ингибитора пути тканевого фактора | |
UA113609C2 (xx) | Антигензв'язуючий білок, який зв'язує людський il-23 | |
EA200700175A1 (ru) | Композиции и способы лечения воспалительных заболеваний | |
EA200900954A1 (ru) | Способ получения связывающей молекулы, специфичной к белку, ассоциированному с расстройством, или антитела, или его связывающего фрагмента, или по меньшей мере одной цепи иммуноглобулина, связывающих вышеуказанный белок (варианты), связывающая молекула, антитело, цепь иммуноглобулина или их связывающий фрагмент (варианты), антиген, полинуклеотид, вектор и клетка-хозяин, их включающие композиция и набор и способ диагностики или лечения неврологических расстройств посредством вышеуказанных объектов (варианты) | |
EA200970477A1 (ru) | Человеческие моноклональные антитела к btla и способы применения | |
EA201100694A1 (ru) | Антитело к cd38 человека и его применение | |
EP1855719A4 (en) | NEUTRALIZING MONOCLONAL ANTIBODIES TO CORONAVIRES IN CONNECTION WITH HEAVY ACUTE RESPIRATORY SYNDROME | |
NZ594682A (en) | Fully human antibodies specific to cadm1 | |
TR201907261T4 (tr) | DKK-1 antikorları. | |
EP2210939A4 (en) | ANTIBODY ANTI-BST2 | |
EA201170764A1 (ru) | Моноклональные антитела против ферропортина 1 и их применение | |
RU2016102202A (ru) | Биологический маркер опухоли | |
ATE470478T1 (de) | An ovarialkrebs beteiligtes protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AZ BY KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM KZ RU |